Advertisement
Advertisement
Investor Relations /
IPO Quote Profile
Banking & finance
Biotech-led boom as 8 China firms flock to Hong Kong’s thriving stock market
AI-powered drug developer Metis TechBio leads group that includes developers of autonomous driving technology and industrial robots.
22 Apr 2026 - 4:53PM
IPO
Sigenergy jumps 103% in Hong Kong debut on rising energy storage demand
16 Apr 2026 - 9:09PM
Banking & finance
Global funds fuel Hong Kong IPO rebound as investors rebalance China portfolios
15 Apr 2026 - 8:13PM
IPO
Huaqin’s US$580 million Hong Kong share sale attracts JPMorgan and UBS
The Shanghai-listed firm is selling 58.55 million shares, pricing them at a 31.2 per cent discount to their last-traded mainland stock price.
15 Apr 2026 - 2:00PM
China’s Huaqin is one of the world’s largest consumer electronics original design manufacturers. Photo: Handout
Banking & finance
Stricter Chinese scrutiny of offshore vehicles a blow for tech IPO candidates
Mainland’s stock market watchdog is discouraging establishment of ‘red-chip-structured’ companies in sensitive industries.
8 Apr 2026 - 10:53AM
Banking & finance
Chinese company to use AI-powered testing to boost profits and fast-track IVF
China’s falling fertility rate sees spike in demand for assisted reproduction as biotech firm raises US$101 million from Hong Kong listing.
30 Mar 2026 - 4:35PM
videocam
Advertisement
Advertisement
Advertisement
Banking & finance
Tong Ren Tang unit pulls Hong Kong IPO in first postponement this year
Hospital-network operator delays plan to raise up to US$115 million amid tepid demand.
27 Mar 2026 - 4:52PM
videocam
A view of Exchange Square in Central, where Hong Kong’s bourse operator has its headquarters, on March 13, 2026. Photo: Jelly Tse
Banking & finance
Hong Kong attracts wave of biotech IPO filings amid AI drug research boom
More than 10 pre-profit drug developers are seeking Hong Kong listings as AI-powered biotech platforms draw growing investor interest.
16 Mar 2026 - 2:38PM
Banking & finance
China investors energise Hong Kong biotech stocks. Is foreign money missing out?
Stock Connect reshuffle reflects biotech sector’s growing role on international stage, though overseas funds remain cautious.
10 Mar 2026 - 5:26PM
IPO
Hong Kong’s IPO pace picks up as 2 mainland Chinese firms get listing approval
Everdisplay Optronics and Galaxis Technology publish post-hearing information packs on the Hong Kong stock exchange.
9 Mar 2026 - 11:49AM
IPO
HSBC chairman floats ‘IPO connect’ for Hong Kong, Shenzhen listings
Modelled on Stock Connect, the proposal would give investors in the Greater Bay Area cross-border access to new share listings.
3 Mar 2026 - 6:43PM
Bull statues are seen in front of the Shenzhen Stock Exchange on November 17, 2024. Photo: Getty Images
IPO
Shenzhen-listed Unisplendour abandons plan to raise funds in Hong Kong
The Tsinghua Holdings arm, however, will raise US$800 million via a private share placement on Shenzhen exchange.
12 Feb 2026 - 8:00AM
Made in China 2025
Chinese healthcare firms expand overseas to support growing expat community
Privately owned Distinct Healthcare plans to open a clinic in Dubai, while TCM group Gushengtang eyes 50 centres in Southeast Asia.
11 Feb 2026 - 5:08PM
Hong Kong
AI chip supplier Axera trades flat in Hong Kong debut as investor frenzy cools
Axera attracted HK$22.34 billion from retail investors during the bookbuilding period, marking an oversubscription of 74.4 times.
10 Feb 2026 - 5:58PM
IPO
China’s biggest pork producer Muyuan flat in Hong Kong share debut
Firm’s US$1.4 billion IPO records lower oversubscription rate than other recent listings, reflecting a cooling of the red-hot market.
7 Feb 2026 - 12:45AM
Muyuan Foods chairman Qin Yinglin (left) takes part in the company’s listing ceremony at Hong Kong Exchanges and Clearing on February 6, 2026. Photo: Jonathan Wong
IPO
3 Chinese firms add to Hong Kong’s IPO boom with US$2 billion in fundraising
Muyuan Foods, Shenzhen Han’s and Distinct Healthcare started taking orders for their Hong Kong listings on Thursday.
29 Jan 2026 - 4:32PM
IPO
Chinese drinks maker Eastroc’s US$1.3 billion Hong Kong IPO gives it wings
Shanghai-listed firm is selling 40.9 million shares for HK$248 each, which would give it a market cap of about US$21 billion.
26 Jan 2026 - 4:49PM
Advertisement
Advertisement
Advertisement
Mainland China
China’s rocket start-ups push the envelope as IPOs gather pace
A policy-backed push to build commercial space champions is reshaping China’s IPO pipeline, with regulators signalling faster pathways.
23 Jan 2026 - 3:30PM
A Zhuque-3 rocket by China’s private rocket firm LandSpace takes off from the Jiuquan Satellite Launch Centre. Photo: Handout
IPO
China’s Busy Ming to test investor appetite with Hong Kong IPO
Snack and drink retailer aims to raise up to US$428 million, but listing plan comes amid weak mainland domestic demand.
20 Jan 2026 - 12:15PM
IPO
Chinese AI start-up MiniMax shines on Hong Kong IPO debut
The shares jump as much as 113.2 per cent to HK$351.80 before ending the day 109.1 per cent higher at HK$345.
9 Jan 2026 - 5:07PM
Banking & finance
TCM firms eye Hong Kong IPOs to fuel global expansion
Over the past year, 34 innovation and technology, life and health science companies set up or expanded their operations in Hong Kong.
8 Jan 2026 - 7:54PM
IPO
3 Chinese AI, robotics stocks gain in Hong Kong debuts
Zhipu AI, Iluvatar CoreX and Edge Medical raised US$1.2 billion in their share offerings.
8 Jan 2026 - 4:26PM
Zhipu AI is the first pure-play Chinese AI large language model developer traded on the Hong Kong stock exchange. Photo: Shutterstock
IPO
MiniMax’s Hong Kong IPO set to hit US$538 million amid Chinese AI sector frenzy
The Alibaba-backed firm is set to price its 25.4 million shares at HK$165 each, the top end of its marketed range, sources say.
5 Jan 2026 - 4:39PM
Banking & finance
The ‘biology winter’ thaws: why investors are buying Hong Kong’s biotech IPOs
A wave of China out-licensing deals is feeding a biotech comeback in Hong Kong, where IPOs and follow-on placements are surging.
5 Jan 2026 - 11:08AM
Hong Kong
Baidu spin-off Kunlunxin joins wave of Chinese semiconductor IPOs in Hong Kong
Last year, 20 Chinese semiconductor IPOs raised over 45 billion yuan (US$6.4 billion), with six of them listing in December.
2 Jan 2026 - 4:49PM
Help preserve 120 years of quality journalism.
SUPPORT NOW
